Rituximab established as the drug of choice in patients with severe disease relapse, though cyclophosphamide may still play an important role for some patients, say rheumatologists
Maintenance of Remission in ANCA-Associated Vasculitis
Relapses are common, but difficult to predict and prevent.
Drug Updates: Lorcaserin, Acetaminophen, and More
information on new approvals and medication safety
Inflammatory Myopathies in Children
Treatment options and recent research for juvenile dermatomyositis.
Drug Updates
Information on new approvals and medication safety.
Clinical Opportunities at the 2012 ACR/ARHP Annual Meeting
The Annual Meeting will provide numerous opportunities to learn the latest clinical findings in the field and to update their knowledge in all aspects of rheumatology.
Case Study: 66-Year-Old Man with Visual Loss, Headache, Hematuria, Chronic Sinusitis
A 66-year-old man presented to the hospital with left-sided visual loss, headache, hematuria, and symptoms of a chronic sinusitis.
ACR/ARHP Annual Scientific Meeting Plenary Highlights Targets and Treatments for Several Diseases
Promising therapeutic targets for rheumatic diseases were the focus of a plenary session here at the ACR/ARHP 2011 Annual Scientific Meeting in November. Presenters discussed discoveries and treatments for systemic sclerosis, rheumatoid arthritis, vasculitis, and Behçet’s disease.
Best Lupus Treatment Still Up for Debate
Panel looks at decision making for treatment of three high-risk patients
- « Previous Page
- 1
- …
- 6
- 7
- 8